Cargando…

P1393: HIGHER DOSE OF CD34+ CELLS PROMOTES EARLY RECONSTITUTION OF NATURAL KILLER CELLS AND IS ASSOCIATED WITH BETTER OUTCOMES AFTER UNMANIPULATED HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MYELOID MALIGNAN

Detalles Bibliográficos
Autores principales:	Zhao, F., Jiang, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429261/ http://dx.doi.org/10.1097/01.HS9.0000848432.79949.52

Ejemplares similares

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
por: Blystad, AK, et al.
Publicado: (2001)

Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation
por: Ullah, Md Ashik, et al.
Publicado: (2016)

1393. Tuberculosis (TB) After Solid-organ Transplant (SOT) and Hematopoietic Stem Cell Transplant (HSCT)
por: Peña-Puga, Cecilia F, et al.
Publicado: (2019)

P1393: BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH REFRACTORY OR RELAPSED B-CELL LYMPHOMA
por: Luo, Wenjing, et al.
Publicado: (2023)

P1388: A SINGLE-ARM, PROSPECTIVE MULTICENTER CLINICAL STUDY OF RELATED HLA HAPLOIDENTICAL PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION FOR HEMATOLOGICAL MALIGNAN
por: Yuan, H., et al.
Publicado: (2022)

Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation
por: Zhou, Ziwei, et al.
Publicado: (2023)

Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation
por: Casorati, Giulia, et al.
Publicado: (2012)

Establishment of Cell Lines from Both Myeloma Bone Marrow and Plasmacytoma: SNU_MM1393_BM and SNU_MM1393_SC from a Single Patient
por: Koh, Youngil, et al.
Publicado: (2014)

PB2439: EARLIER ENGRAFTMENT WITHOUT INCREASE OF GVHD IN HIGHER DOSE OF CD34+ CELLS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Tan, Tran-Der, et al.
Publicado: (2023)

Predicting CD4 T‐Cell Reconstitution Following Pediatric Hematopoietic Stem Cell Transplantation
por: Hoare, RL, et al.
Publicado: (2017)

ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-Identical Peripheral Blood Hematopoietic Stem Cell Transplantation
por: Yang, Nan, et al.
Publicado: (2019)

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
por: Ciceri, Fabio, et al.
Publicado: (2011)

P1348: COMPARISON OF NATURAL KILLER CELL RECONSTITUTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION DEPENDING ON THE VARIANT OF T-CELL DEPLETION
por: Konova, Z., et al.
Publicado: (2022)

Recipient bone marrow assimilates the myeloid/lymphoid reconstitution of distinct fetal hematopoietic stem cells
por: Guo, Xiao-Lin, et al.
Publicado: (2017)

Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells
Publicado: (1991)

Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells
por: Shi, Qiang, et al.
Publicado: (2013)

Rapid Recovery of CD3(+)CD8(+) T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation
por: Tian, Deng-Mei, et al.
Publicado: (2016)

Exogenous endothelial cells as accelerators of hematopoietic reconstitution
por: Mizer, J Christopher, et al.
Publicado: (2012)

Unmanipulated haploidentical transplantation for adult patients with hematological malignancies
por: Ruggeri, Annalisa, et al.
Publicado: (2019)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
por: Dou, Li-Ping, et al.
Publicado: (2018)

Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
por: Dekker, Linde, et al.
Publicado: (2020)

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
por: Huang, Junbin, et al.
Publicado: (2023)

P1288: UNMANIPULATED PERIPHERAL HAPLOIDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANT IS AN EFFECTIVE CONSOLIDATIVE STRATEGY FOR HIGH-RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME
por: Serpenti, Fabio, et al.
Publicado: (2023)

Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34(+ )bone marrow cells, following gamma irradiation in cynomolgus macaques
por: Derdouch, Sonia, et al.
Publicado: (2008)

Epigenetic changes during hematopoietic cell granulocytic differentiation – comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils
por: Navakauskienė, Rūta, et al.
Publicado: (2014)

Transient loading of CD34(+) hematopoietic progenitor cells with polystyrene nanoparticles
por: Deville, Sarah, et al.
Publicado: (2017)

Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells
por: Serafini, Marta, et al.
Publicado: (2007)

Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells
por: Serafini, Marta, et al.
Publicado: (2007)

CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan
por: Ayano, Masahiro, et al.
Publicado: (2019)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation
por: Andrlová, Hana, et al.
Publicado: (2021)

Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
por: Greiner, Jochen, et al.
Publicado: (2019)

Long term immune reconstitution after immunoablation and autologous CD34 cell therapy in autoimmune diseases
por: Thiel, AT, et al.
Publicado: (2002)

Reforma al artículo 1393 del nuevo código de comercio
por: Bache Herrera, Arturo
Publicado: (1998)

Pre-Surgical Sedation, Montpellier c.1393: Testimony of Lawrence of Lindores
por: Moonan, L.
Publicado: (1968)

Correction to Lancet Glob Health 2023; 11: e1393–401
Publicado: (2023)

Upregulation of CD11A on Hematopoietic Stem Cells Denotes the Loss of Long-Term Reconstitution Potential
por: Fathman, John W., et al.
Publicado: (2014)

The CD34(+) Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
por: Remberger, M., et al.
Publicado: (2020)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

Fanconi anemia genes are highly expressed in primitive CD34(+ )hematopoietic cells
por: Aubé, Michel, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_sgdq5cs5q6f0figmd8ecglia4h